Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase II Trial of Guadecitabine Plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

pubmed(2023)

Cited 1|Views30
No score
Key words
Urothelial Carcinoma,Immune Checkpoint Blockade,Combination Therapies,Cancer Immunoediting,Biomarkers for Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined